Hematopoietic cell transplantation (HCT)
Clinical trials for Hematopoietic cell transplantation (HCT) explained in plain language.
Never miss a new study
Get alerted when new Hematopoietic cell transplantation (HCT) trials appear
Sign up with your email to follow new studies for Hematopoietic cell transplantation (HCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can patients stop Anti-Rejection drugs sooner after transplant?
Disease control Recruiting nowThis study tests whether patients can safely stop the drug tacrolimus earlier than usual after a stem cell transplant. Tacrolimus is given to prevent graft-versus-host disease (GVHD), but newer methods have lowered GVHD risk. The trial will enroll 50 people with blood cancers and…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New drug combo aims to make bone marrow transplants safer for rare blood cancer
Disease control Recruiting nowThis early-stage trial tests the safety and best dose of the drug momelotinib when given before, during, and after a stem cell transplant for people with myelofibrosis, a serious bone marrow disorder. About 28 participants will receive momelotinib pills daily for up to 13 cycles.…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC